The University of Chicago Header Logo

Connection

Emily Rogalski to Humans

Back to Details
This is a "connection" page, showing publications Emily Rogalski has written about Humans.
Emily Rogalski
Connection Strength
1.387
Humans
  1. Medical characterization of cognitive SuperAgers: Investigating the medication profile of SuperAgers. J Am Geriatr Soc. 2023 11; 71(11):3638-3641.
    View in: PubMed
    Score: 0.029
  2. Frontotemporal Degeneration with Transactive Response DNA-Binding Protein Type C at the Anterior Temporal Lobe. Ann Neurol. 2023 07; 94(1):1-12.
    View in: PubMed
    Score: 0.029
  3. The Wernicke conundrum is misinterpreted. Brain. 2023 04 19; 146(4):e21-e22.
    View in: PubMed
    Score: 0.029
  4. Suitability of Goal Attainment Scaling in Older Adult Populations with Neurodegenerative Disease Experiencing Cognitive Impairment: A Systematic Review and Meta-Analysis. Gerontology. 2023; 69(8):1002-1013.
    View in: PubMed
    Score: 0.029
  5. Broadening the identification of superior cognition in older age. Arq Neuropsiquiatr. 2023 02; 81(2):105-106.
    View in: PubMed
    Score: 0.029
  6. Use and Perceived Effectiveness of Communication Modes Reported by Persons With Primary Progressive Aphasia. Am J Speech Lang Pathol. 2023 01 11; 32(1):298-305.
    View in: PubMed
    Score: 0.028
  7. Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology. Acta Neuropathol Commun. 2022 08 09; 10(1):111.
    View in: PubMed
    Score: 0.027
  8. Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia. Brain. 2022 06 30; 145(6):2133-2148.
    View in: PubMed
    Score: 0.027
  9. Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia. Trials. 2022 Jun 13; 23(1):487.
    View in: PubMed
    Score: 0.027
  10. Communication Partner Engagement: A Relevant Factor for Functional Outcomes in Speech-Language Therapy for Aphasic Dementia. J Gerontol B Psychol Sci Soc Sci. 2022 06 01; 77(6):1017-1025.
    View in: PubMed
    Score: 0.027
  11. NIH Toolbox® Episodic Memory Measure Differentiates Older Adults with Exceptional Memory Capacity from those with Average-for-Age Cognition. J Int Neuropsychol Soc. 2023 Feb; 29(2):230-234.
    View in: PubMed
    Score: 0.027
  12. The Reliability of Telepractice Administration of the Western Aphasia Battery-Revised in Persons With Primary Progressive Aphasia. Am J Speech Lang Pathol. 2022 03 10; 31(2):881-895.
    View in: PubMed
    Score: 0.027
  13. Relationships among tau burden, atrophy, age, and naming in the aphasic variant of Alzheimer's disease. Alzheimers Dement. 2021 11; 17(11):1788-1797.
    View in: PubMed
    Score: 0.026
  14. Neuropsychological Profiles of Older Adults with Superior versus Average Episodic Memory: The Northwestern "SuperAger" Cohort. J Int Neuropsychol Soc. 2022 07; 28(6):563-573.
    View in: PubMed
    Score: 0.026
  15. Modularity and granularity across the language network-A primary progressive aphasia perspective. Cortex. 2021 08; 141:482-496.
    View in: PubMed
    Score: 0.025
  16. Functional decline in the aphasic variant of Alzheimer's disease. Alzheimers Dement. 2021 10; 17(10):1641-1648.
    View in: PubMed
    Score: 0.025
  17. Memory Resilience in Alzheimer Disease With Primary Progressive Aphasia. Neurology. 2021 02 09; 96(6):e916-e925.
    View in: PubMed
    Score: 0.025
  18. Differential neurocognitive network perturbation in amnestic and aphasic Alzheimer disease. Neurology. 2020 02 18; 94(7):e699-e704.
    View in: PubMed
    Score: 0.023
  19. Clinical and cortical decline in the aphasic variant of Alzheimer's disease. Alzheimers Dement. 2019 04; 15(4):543-552.
    View in: PubMed
    Score: 0.022
  20. Word comprehension in temporal cortex and Wernicke area: A PPA perspective. Neurology. 2019 01 15; 92(3):e224-e233.
    View in: PubMed
    Score: 0.021
  21. A Life Participation Approach to Primary Progressive Aphasia Intervention. Semin Speech Lang. 2018 07; 39(3):284-296.
    View in: PubMed
    Score: 0.021
  22. Cognitive trajectories and spectrum of neuropathology in SuperAgers: The first 10 cases. Hippocampus. 2019 05; 29(5):458-467.
    View in: PubMed
    Score: 0.020
  23. Psychological well-being in elderly adults with extraordinary episodic memory. PLoS One. 2017; 12(10):e0186413.
    View in: PubMed
    Score: 0.020
  24. Selective verbal recognition memory impairments are associated with atrophy of the language network in non-semantic variants of primary progressive aphasia. Neuropsychologia. 2017 06; 100:10-17.
    View in: PubMed
    Score: 0.019
  25. Rates of Cortical Atrophy in Adults 80 Years and Older With Superior vs Average Episodic Memory. JAMA. 2017 04 04; 317(13):1373-1375.
    View in: PubMed
    Score: 0.019
  26. Development of a Psycho-Educational Support Program for Individuals with Primary Progressive Aphasia and their Care-Partners. Dementia (London). 2019 May; 18(4):1310-1327.
    View in: PubMed
    Score: 0.019
  27. Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features. Neurology. 2016 Sep 27; 87(13):1337-43.
    View in: PubMed
    Score: 0.018
  28. Will You Still Need Me When I'm 64, or 84, or 104? The Importance of Speech-Language Pathologists in Promoting the Quality of Life of Aging Adults in the United States into the Future. Semin Speech Lang. 2016 08; 37(3):185-200.
    View in: PubMed
    Score: 0.018
  29. The Wernicke conundrum and the anatomy of language comprehension in primary progressive aphasia. Brain. 2015 Aug; 138(Pt 8):2423-37.
    View in: PubMed
    Score: 0.017
  30. The CARE pathway model for dementia: psychosocial and rehabilitative strategies for care in young-onset dementias. Psychiatr Clin North Am. 2015 Jun; 38(2):333-52.
    View in: PubMed
    Score: 0.016
  31. Association between the prevalence of learning disabilities and primary progressive aphasia. JAMA Neurol. 2014 Dec; 71(12):1576-7.
    View in: PubMed
    Score: 0.016
  32. Asymmetry of cortical decline in subtypes of primary progressive aphasia. Neurology. 2014 Sep 23; 83(13):1184-91.
    View in: PubMed
    Score: 0.016
  33. Longitudinal neuropsychological performance of cognitive SuperAgers. J Am Geriatr Soc. 2014 Aug; 62(8):1598-600.
    View in: PubMed
    Score: 0.016
  34. Naming vs knowing faces in primary progressive aphasia: a tale of 2 hemispheres. Neurology. 2013 Aug 13; 81(7):658-64.
    View in: PubMed
    Score: 0.015
  35. A novel frontal pathway underlies verbal fluency in primary progressive aphasia. Brain. 2013 Aug; 136(Pt 8):2619-28.
    View in: PubMed
    Score: 0.015
  36. Behavioural interventions for enhancing life participation in behavioural variant frontotemporal dementia and primary progressive aphasia. Int Rev Psychiatry. 2013 Apr; 25(2):237-45.
    View in: PubMed
    Score: 0.014
  37. Are there susceptibility factors for primary progressive aphasia? Brain Lang. 2013 Nov; 127(2):135-8.
    View in: PubMed
    Score: 0.014
  38. Words and objects at the tip of the left temporal lobe in primary progressive aphasia. Brain. 2013 Feb; 136(Pt 2):601-18.
    View in: PubMed
    Score: 0.014
  39. Youthful memory capacity in old brains: anatomic and genetic clues from the Northwestern SuperAging Project. J Cogn Neurosci. 2013 Jan; 25(1):29-36.
    View in: PubMed
    Score: 0.014
  40. Superior memory and higher cortical volumes in unusually successful cognitive aging. J Int Neuropsychol Soc. 2012 Nov; 18(6):1081-5.
    View in: PubMed
    Score: 0.014
  41. ApoE E4 is a susceptibility factor in amnestic but not aphasic dementias. Alzheimer Dis Assoc Disord. 2011 Apr-Jun; 25(2):159-63.
    View in: PubMed
    Score: 0.013
  42. Anatomy of language impairments in primary progressive aphasia. J Neurosci. 2011 Mar 02; 31(9):3344-50.
    View in: PubMed
    Score: 0.012
  43. Covert processing of words and pictures in nonsemantic variants of primary progressive aphasia. Alzheimer Dis Assoc Disord. 2008 Oct-Dec; 22(4):343-51.
    View in: PubMed
    Score: 0.011
  44. Increased frequency of learning disability in patients with primary progressive aphasia and their first-degree relatives. Arch Neurol. 2008 Feb; 65(2):244-8.
    View in: PubMed
    Score: 0.010
  45. An update on primary progressive aphasia. Curr Neurol Neurosci Rep. 2007 Sep; 7(5):388-92.
    View in: PubMed
    Score: 0.010
  46. Primary progressive aphasia: relationship between gender and severity of language impairment. Cogn Behav Neurol. 2007 Mar; 20(1):38-43.
    View in: PubMed
    Score: 0.009
  47. False recognition of incidentally learned pictures and words in primary progressive aphasia. Neuropsychologia. 2007 Jan 28; 45(2):368-77.
    View in: PubMed
    Score: 0.009
  48. A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce. JAMA Netw Open. 2024 Aug 01; 7(8):e2427073.
    View in: PubMed
    Score: 0.008
  49. Measuring Multidimensional Aspects of Health in the Oldest Old Using the NIH Toolbox: Results From the ARMADA Study. Arch Clin Neuropsychol. 2024 Jul 24; 39(5):535-546.
    View in: PubMed
    Score: 0.008
  50. Managing medications among individuals with mild cognitive impairment and dementia: Patient-caregiver perspectives. J Am Geriatr Soc. 2024 Oct; 72(10):3011-3021.
    View in: PubMed
    Score: 0.008
  51. Phenotypically concordant distribution of pick bodies in aphasic versus behavioral dementias. Acta Neuropathol Commun. 2024 Feb 22; 12(1):31.
    View in: PubMed
    Score: 0.008
  52. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis. Lancet Neurol. 2024 02; 23(2):168-177.
    View in: PubMed
    Score: 0.008
  53. Death Induced by Survival gene Elimination (DISE) correlates with neurotoxicity in Alzheimer's disease and aging. Nat Commun. 2024 Jan 18; 15(1):264.
    View in: PubMed
    Score: 0.008
  54. Neural mechanisms of sentence production: a volumetric study of primary progressive aphasia. Cereb Cortex. 2024 01 14; 34(1).
    View in: PubMed
    Score: 0.008
  55. The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort. Alzheimers Dement. 2023 11; 19 Suppl 9:S74-S88.
    View in: PubMed
    Score: 0.007
  56. Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort. Alzheimers Dement. 2023 11; 19 Suppl 9:S64-S73.
    View in: PubMed
    Score: 0.007
  57. Behavioral Treatment for Speech and Language in Primary Progressive Aphasia and Primary Progressive Apraxia of Speech: A Systematic Review. Neuropsychol Rev. 2024 Sep; 34(3):882-923.
    View in: PubMed
    Score: 0.007
  58. Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS). Alzheimers Dement. 2023 11; 19 Suppl 9:S98-S114.
    View in: PubMed
    Score: 0.007
  59. Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease. Alzheimers Dement. 2023 11; 19 Suppl 9:S29-S41.
    View in: PubMed
    Score: 0.007
  60. Sex and APOE e4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease. Alzheimers Dement. 2023 11; 19 Suppl 9:S49-S63.
    View in: PubMed
    Score: 0.007
  61. White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS). Alzheimers Dement. 2023 11; 19 Suppl 9:S89-S97.
    View in: PubMed
    Score: 0.007
  62. Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study. Alzheimers Dement. 2023 11; 19 Suppl 9:S115-S125.
    View in: PubMed
    Score: 0.007
  63. Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort. Alzheimers Dement. 2023 11; 19 Suppl 9:S42-S48.
    View in: PubMed
    Score: 0.007
  64. Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection. Alzheimers Dement. 2023 11; 19 Suppl 9:S8-S18.
    View in: PubMed
    Score: 0.007
  65. Learning slopes in early-onset Alzheimer's disease. Alzheimers Dement. 2023 11; 19 Suppl 9:S19-S28.
    View in: PubMed
    Score: 0.007
  66. Evaluating the association between genetically proxied ACE inhibition and dementias. Alzheimers Dement. 2023 09; 19(9):3894-3901.
    View in: PubMed
    Score: 0.007
  67. Evaluating the Association Between Genetically Proxied Neurodevelopmental Language Phenotypes and the Risk of Primary Progressive Aphasia. Neurology. 2023 05 02; 100(18):e1922-e1929.
    View in: PubMed
    Score: 0.007
  68. Differential vulnerability of the dentate gyrus to tauopathies in dementias. Acta Neuropathol Commun. 2023 01 03; 11(1):1.
    View in: PubMed
    Score: 0.007
  69. Integrity of Neuronal Size in the Entorhinal Cortex Is a Biological Substrate of Exceptional Cognitive Aging. J Neurosci. 2022 11 09; 42(45):8587-8594.
    View in: PubMed
    Score: 0.007
  70. Eye movements as a measure of word comprehension deficits in primary progressive aphasia. Brain Lang. 2022 09; 232:105165.
    View in: PubMed
    Score: 0.007
  71. Cortical and subcortical pathological burden and neuronal loss in an autopsy series of FTLD-TDP-type C. Brain. 2022 04 29; 145(3):1069-1078.
    View in: PubMed
    Score: 0.007
  72. ARMADA: Assessing reliable measurement in Alzheimer's disease and cognitive aging project methods. Alzheimers Dement. 2022 08; 18(8):1449-1460.
    View in: PubMed
    Score: 0.007
  73. Paucity of Entorhinal Cortex Pathology of the Alzheimer's Type in SuperAgers with Superior Memory Performance. Cereb Cortex. 2021 06 10; 31(7):3177-3183.
    View in: PubMed
    Score: 0.006
  74. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology. Alzheimers Dement. 2021 12; 17(12):2043-2055.
    View in: PubMed
    Score: 0.006
  75. Nosology of Primary Progressive Aphasia and the Neuropathology of Language. Adv Exp Med Biol. 2021; 1281:33-49.
    View in: PubMed
    Score: 0.006
  76. Primary Progressive Aphasia has a Unique Signature Distinct from Dementia of the Alzheimer's Type and Behavioral Variant Frontotemporal Dementia Regardless of Pathology. J Neuropathol Exp Neurol. 2020 12 04; 79(12):1379-1381.
    View in: PubMed
    Score: 0.006
  77. Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer's disease. Brain Pathol. 2021 01; 31(1):189-204.
    View in: PubMed
    Score: 0.006
  78. Familial language network vulnerability in primary progressive aphasia. Neurology. 2020 08 18; 95(7):e847-e855.
    View in: PubMed
    Score: 0.006
  79. Montreal Cognitive Assessment (MoCA) Performance and Domain-Specific Index Scores in Amnestic Versus Aphasic Dementia. J Int Neuropsychol Soc. 2020 10; 26(9):927-931.
    View in: PubMed
    Score: 0.006
  80. Speech and Language Presentations of FTLD-TDP Type B Neuropathology. J Neuropathol Exp Neurol. 2020 03 01; 79(3):277-283.
    View in: PubMed
    Score: 0.006
  81. Anatomical evidence of an indirect pathway for word repetition. Neurology. 2020 02 11; 94(6):e594-e606.
    View in: PubMed
    Score: 0.006
  82. Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration. Alzheimers Dement. 2020 01; 16(1):37-48.
    View in: PubMed
    Score: 0.006
  83. Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration. Alzheimers Dement. 2020 01; 16(1):49-59.
    View in: PubMed
    Score: 0.006
  84. Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Alzheimers Dement. 2020 01; 16(1):118-130.
    View in: PubMed
    Score: 0.006
  85. Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium. Alzheimers Dement. 2020 01; 16(1):106-117.
    View in: PubMed
    Score: 0.006
  86. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimers Dement. 2020 01; 16(1):11-21.
    View in: PubMed
    Score: 0.006
  87. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol. 2020 02; 19(2):145-156.
    View in: PubMed
    Score: 0.006
  88. APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort. Neurology. 2020 02 11; 94(6):e607-e612.
    View in: PubMed
    Score: 0.006
  89. What are the later life contributions to reserve, resilience, and compensation? Neurobiol Aging. 2019 11; 83:140-144.
    View in: PubMed
    Score: 0.006
  90. Verb-argument integration in primary progressive aphasia: Real-time argument access and selection. Neuropsychologia. 2019 11; 134:107192.
    View in: PubMed
    Score: 0.006
  91. Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease. Brain Pathol. 2020 03; 30(2):332-344.
    View in: PubMed
    Score: 0.006
  92. Perturbations of language network connectivity in primary progressive aphasia. Cortex. 2019 12; 121:468-480.
    View in: PubMed
    Score: 0.006
  93. FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology. J Neuropathol Exp Neurol. 2019 09 01; 78(9):844-853.
    View in: PubMed
    Score: 0.006
  94. Speech and language therapy approaches to managing primary progressive aphasia. Pract Neurol. 2020 Apr; 20(2):154-161.
    View in: PubMed
    Score: 0.006
  95. Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes. Acta Neuropathol. 2019 07; 138(1):167-169.
    View in: PubMed
    Score: 0.005
  96. A Highly Sensitive Sandwich ELISA to Detect CSF Progranulin: A Potential Biomarker for CNS Disorders. J Neuropathol Exp Neurol. 2019 05 01; 78(5):406-415.
    View in: PubMed
    Score: 0.005
  97. Introduction to the de Toledo Morrell special issue. Hippocampus. 2019 05; 29(5):407-408.
    View in: PubMed
    Score: 0.005
  98. Genetic screen in a large series of patients with primary progressive aphasia. Alzheimers Dement. 2019 04; 15(4):553-560.
    View in: PubMed
    Score: 0.005
  99. Prevalence of amyloid-ß pathology in distinct variants of primary progressive aphasia. Ann Neurol. 2018 11; 84(5):729-740.
    View in: PubMed
    Score: 0.005
  100. Atrophy and microglial distribution in primary progressive aphasia with transactive response DNA-binding protein-43 kDa. Ann Neurol. 2018 06; 83(6):1096-1104.
    View in: PubMed
    Score: 0.005
  101. A nonverbal route to conceptual knowledge involving the right anterior temporal lobe. Neuropsychologia. 2018 08; 117:92-101.
    View in: PubMed
    Score: 0.005
  102. Combined Pathologies in FTLD-TDP Types A and C. J Neuropathol Exp Neurol. 2018 05 01; 77(5):405-412.
    View in: PubMed
    Score: 0.005
  103. Variations in Acetylcholinesterase Activity within Human Cortical Pyramidal Neurons Across Age and Cognitive Trajectories. Cereb Cortex. 2018 04 01; 28(4):1329-1337.
    View in: PubMed
    Score: 0.005
  104. Von Economo neurons of the anterior cingulate across the lifespan and in Alzheimer's disease. Cortex. 2018 02; 99:69-77.
    View in: PubMed
    Score: 0.005
  105. Objective features of subjective cognitive decline in a United States national database. Alzheimers Dement. 2017 Dec; 13(12):1337-1344.
    View in: PubMed
    Score: 0.005
  106. Functional Connectivity is Reduced in Early-stage Primary Progressive Aphasia When Atrophy is not Prominent. Alzheimer Dis Assoc Disord. 2017 Apr-Jun; 31(2):101-106.
    View in: PubMed
    Score: 0.005
  107. A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction. Brain. 2017 Apr 01; 140(4):1128-1146.
    View in: PubMed
    Score: 0.005
  108. Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia. Alzheimers Dement. 2017 May; 13(5):598-601.
    View in: PubMed
    Score: 0.005
  109. Neuropathologic Associations of Learning and Memory in Primary Progressive Aphasia. JAMA Neurol. 2016 07 01; 73(7):846-52.
    View in: PubMed
    Score: 0.004
  110. Frontotemporal networks and behavioral symptoms in primary progressive aphasia. Neurology. 2016 04 12; 86(15):1393-1399.
    View in: PubMed
    Score: 0.004
  111. Is in vivo amyloid distribution asymmetric in primary progressive aphasia? Ann Neurol. 2016 Mar; 79(3):496-501.
    View in: PubMed
    Score: 0.004
  112. What do pauses in narrative production reveal about the nature of word retrieval deficits in PPA? Neuropsychologia. 2015 Oct; 77:211-22.
    View in: PubMed
    Score: 0.004
  113. Eye movements as probes of lexico-semantic processing in a patient with primary progressive aphasia. Neurocase. 2016; 22(1):65-75.
    View in: PubMed
    Score: 0.004
  114. Morphometric and histologic substrates of cingulate integrity in elders with exceptional memory capacity. J Neurosci. 2015 Jan 28; 35(4):1781-91.
    View in: PubMed
    Score: 0.004
  115. Primary progressive aphasia and the evolving neurology of the language network. Nat Rev Neurol. 2014 Oct; 10(10):554-69.
    View in: PubMed
    Score: 0.004
  116. Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. Brain. 2014 Apr; 137(Pt 4):1176-92.
    View in: PubMed
    Score: 0.004
  117. A cortical pathway to olfactory naming: evidence from primary progressive aphasia. Brain. 2013 Apr; 136(Pt 4):1245-59.
    View in: PubMed
    Score: 0.004
  118. Verbal and nonverbal memory in primary progressive aphasia: the Three Words-Three Shapes Test. Behav Neurol. 2013; 26(1-2):67-76.
    View in: PubMed
    Score: 0.004
  119. Anatomic, clinical, and neuropsychological correlates of spelling errors in primary progressive aphasia. Neuropsychologia. 2012 Jul; 50(8):1929-35.
    View in: PubMed
    Score: 0.003
  120. Quantitative classification of primary progressive aphasia at early and mild impairment stages. Brain. 2012 May; 135(Pt 5):1537-53.
    View in: PubMed
    Score: 0.003
  121. Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia. Brain. 2012 May; 135(Pt 5):1554-65.
    View in: PubMed
    Score: 0.003
  122. Neural mechanisms of object naming and word comprehension in primary progressive aphasia. J Neurosci. 2012 Apr 04; 32(14):4848-55.
    View in: PubMed
    Score: 0.003
  123. Semantic interference during object naming in agrammatic and logopenic primary progressive aphasia (PPA). Brain Lang. 2012 Mar; 120(3):237-50.
    View in: PubMed
    Score: 0.003
  124. Quantitative template for subtyping primary progressive aphasia. Arch Neurol. 2009 Dec; 66(12):1545-51.
    View in: PubMed
    Score: 0.003
  125. The northwestern anagram test: measuring sentence production in primary progressive aphasia. Am J Alzheimers Dis Other Demen. 2009 Oct-Nov; 24(5):408-16.
    View in: PubMed
    Score: 0.003
  126. Neurology of anomia in the semantic variant of primary progressive aphasia. Brain. 2009 Sep; 132(Pt 9):2553-65.
    View in: PubMed
    Score: 0.003
  127. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol. 2008 Jun; 63(6):709-19.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.